Related Experiment Video

Updated: May 11, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
09:51

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase

Published on: June 30, 2023

IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity

María J Moreno1, Marguerite Ball, Marina Rukhlova

  • 1National Research Council of Canada, Ottawa, Ontario, Canada. maria.moreno@nrc.ca

Neoplasia (New York, N.Y.)
|May 2, 2013
PubMed

Insights

The C-terminal fragment of Insulin-like Growth Factor-Binding Protein 4 (IGFBP-4) shows potent anti-angiogenic and anti-tumorigenic effects. This fragment, CIBP-4, significantly reduced glioblastoma tumor growth by 60% in preclinical models.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Angiogenesis

Background:

  • Insulin-like growth factor-binding protein 4 (IGFBP-4) exhibits IGF-independent anti-angiogenic and antitumorigenic properties.
  • These activities are localized to the C-terminal fragment of IGFBP-4 (CIBP-4), which contains a thyroglobulin type 1 (Tg1) domain.

Purpose of the Study:

  • To investigate the anti-angiogenic and anti-tumorigenic mechanisms of CIBP-4.
  • To evaluate the therapeutic potential of CIBP-4 in glioblastoma models.

Main Methods:

  • Cellular uptake and co-localization studies in endothelial cells (ECs) and glioblastoma U87MG cells.
  • In vitro assays assessing EC tubulogenesis and cathepsin B (CatB) activity inhibition.
  • Biodistribution analysis and tumor growth assessment in a glioblastoma xenograft mouse model.

Main Results:

  • CIBP-4 internalized and co-localized with lysosomal structures in ECs and glioblastoma cells.
  • CIBP-4 inhibited growth factor-induced EC tubulogenesis and intracellular CatB activity.
  • Intravenously administered CIBP-4 accumulated in tumors and reduced glioblastoma tumor growth by 60%.

Conclusions:

  • The IGFBP-4 C-terminal fragment (CIBP-4) possesses potent anti-angiogenic and anti-tumorigenic activities.
  • CIBP-4's ability to inhibit cathepsins and target tumors suggests significant therapeutic potential for glioblastoma.

More Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...